JPRN-UMIN000036253招募中3 期
Randomized controlled phase III trial to evaluate omentum preserving gastrectomy for patients with advanced gastric cancer (JCOG1711, ROAD-GC) - Randomized controlled phase III trial to evaluate omentum preserving gastrectomy for patients with advanced gastric cancer (JCOG1711, ROAD-GC)
Japan Clinical Oncology Group (JCOG)0 个研究点目标入组 1,050 人开始时间: 2019年3月19日最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 发起方
- 入组人数
- 1,050
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 79years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Synchronous or metachronous (within 5 years) malignancies. 2) Infectious disease requiring systemic treatment. 3) Body temperature of 38 degrees Celsius or higher. 4) During pregnancy, within 28 days of postparturition, or during lactation. 5) Severe mental disease. 6) Receiving continuous systemic corticosteroid or immunosuppressant treatment. 7)History of unstable angina pectoris within three weeks or myocardial infarction within six months before registration. 8)Poorly controlled valve disease, dilated or hypertrophic cardiomyopathy 9)HIV antibody positive 10)Interstitial pneumonia, pulmonary fibrosis, or severe emphysema based on chest CT
研究者
相似试验
招募中
3 期
Randomized controlled phase III trial to investigate superiority of robot-assisted gastrectomy over laparoscopic gastrectomy for clinical stage T1-4aN0-3 Gastric Cancer patients (JCOG1907, MONA LISA study)clinical stage T1-4aN0-3 Gastric CancerJPRN-UMIN000039825Japan Clinical Oncology Group (JCOG)1,040
已完成
3 期
Clinical trial, phase 3, to evaluate the efficacy of CVO + for the treatment of COVID-19.COVID-19PACTR202103601407640PHARAMALAGASY338
进行中（未招募）
不适用
Study to evaluate optimized retreatment and prolonged therapy with bortezomibMedDRA version: 17.1Level: LLTClassification code 10028228Term: Multiple myelomaSystem Organ Class: 100000004864Multiple MyelomaEUCTR2011-004795-11-NLJanssen-Cilag International N.V.240
进行中（未招募）
不适用
Study to evaluate optimized retreatment and prolonged therapy with bortezomibMedDRA version: 17.0Level: LLTClassification code 10028228Term: Multiple myelomaSystem Organ Class: 100000004864Multiple MyelomaEUCTR2011-004795-11-BEJanssen-Cilag International N.V.240
进行中（未招募）
不适用
Study to evaluate optimized retreatment and prolonged therapy with bortezomibMedDRA version: 17.1Level: LLTClassification code 10028228Term: Multiple myelomaSystem Organ Class: 100000004864Multiple MyelomaEUCTR2011-004795-11-PLJanssen-Cilag International N.V.240